Medicon Valley Alliance and WuXi AppTec would like to welcome you to a Boost seminar. Come join us for an informative lunch event at the Medicon Valley Alliance! WuXi AppTec Experts will be sharing their expertise and insights to accelerate new drug discovery, so don’t miss out on this great opportunity to expand your knowledge. […]

Medicon Valley Alliance and Bioneer A/S would like to welcome you to a Boost Seminar on 28th of November 2024. How do you move your drug discovery project, from research, through development and to the clinic, ensuring that all regulatory and quality demands are met? There are specific challenges when the new drug is a […]

Medicon Valley Alliance and Citi would like to welcome you to a boost seminar November 14th in Copenhagen, from 8.30 to 13.30 including networking lunch. The event is a convening forum for senior executives of life sciences, biotechnology, medical technology, and other healthcare companies to learn about key trends driving the investor perspectives, recent developments […]

Medicon Valley Alliance and Labcorp would like to welcome you to an exploration of New Approach Methodologies (NAMs) and their impact on diverse scientific realms. From in vitro alternatives to non-animal methods, NAMs have evolved into an internationally accepted term with industry-agnostic applications. Our sessions will unravel the regulatory landscape, delve into innovative seizure liability […]

Medicon Valley Alliance and AbbVie are pleased to invite you to an Abbvie Partnering Day on the 26th of October in Copenhagen. At AbbVie, we partner to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people’s lives. AbbVie’s Partnering Days provide an opportunity to access senior level Corporate Business Strategy […]

In this seminar two MVA members, TECHNIA and Novo Nordisk, join forces to share more holistic insights about digital trends and tools for sustainable and compliant product creation and warmly welcome you. The Life Sciences industry can create products faster and more efficiently, while ensuring long-term business sustainability and compliancy by understanding trends and taking […]

Join MVA and Catalent at this Boost Seminar focusing on optimizing oral bioavailability and translating formulation advances for clinical success. Oral solid dosage forms remain a preferred option for many pharmaceutical drug developers. However, their successful development and manufacture still present several unique challenges and opportunities. This event brings together pharmaceutical experts to discuss such […]

Join us for this event to explore the lessons learned by senior industry experts who have successfully developed, launched, and commercialised global assets. Through a combination of real-life case-studies, panel discussions, and presentations we will explore how and when you should build your market access and commercialisation strategies, no matter your corporate strategy. This seminar […]

Hear from leaders of Medicon Valley Alliance, Adapvac, Faron, and AGC Biologics, and enjoy happy hour and networking to kick off 2023. Meet Your Local CMO: Connect on Biotech & Capacity Trends in the Medicon Valley. Join us for this limited capacity event to learn about the trends to watch in the Medicon Valley life […]

Do you work in a pharmaceutical or biotech setting looking to accelerate the speed and confidence of your analytics? You are new to some of Bruker Life Science Mass Spectrometry solutions? Or you are curious what we are developing for our existing users? This Boost Seminar in collaboration with Bruker will bring you closer to […]

In a rare visit by one of Canada’s leading hospitals, Medicon Valley Alliance and the Embassy of Canada invites you to a boost seminar with Centre Hospitalier de l’Université de Montreal (CHUM), to discuss opportunities to partner with the hospital on research, innovation and incubation with the hospital and it’s innovation partners. The purpose of […]

– Hosted by Key2Compliance There are a large number of new start-ups in Medical Device and In Vitro Diagnostics in the Medicon Valley area. This seminar will focus on how a start-up in Medical Device or In Vitro Diagnostic can accelerate the development from idea to success within the current framework of regulations. Join us […]

Do you have a strategy for building analytic excellence in your organization?   Your competitors do. Organizations that take an enterprise approach to analytics outperform their competition. By making analytics the cornerstone of problem solving and decision making in every facet of business, you’ll generate more insights, accelerate innovation and create value.  Maybe you work in an […]

The future of pharmaceutical manufacturing is digital For the highly-regulated life sciences and food & beverage industries, Industry 4.0 represents a unique challenge. There is no doubt that the future of all manufacturing is digital. Yet, how do we get there? What is the best approach and how can companies ensure that they follow an […]

Welcome to our Boost Seminar! On the 23rd January 2019 we invite you and your colleagues in the development & regulatory departments to a complimentary seminar on how to fully leverage on oral explanations and other opportunities to convince EU regulators. There are many opportunities for bringing your message across to regulators, by interacting with […]

We are pleased to invite you to our Boost Seminar on the topic Navigating the Shifting Currents of U.S. Biotech and Pharmaceutical Patent Law with King & Spalding. United States patent law is in flux.  Restriction in subject matter eligibility, initial experience with biosimilar patent litigation, application of the new prior art definitions, and recent developments […]

We are pleased to invite you to a half-day seminar where you will learn how to facilitate trial safety and efficacy with automated reporting tools, roll-based workflows and clinical analysis capabilities including risk-based monitoring, data monitoring and fraud detection. Date: Tuesday May 23rd, 2017 Time: 10:00 – 13:30 Venue: Medicon Village, Scheelevägen 2, 223 63 Lund, Sweden – […]

Building on the success from April’s seminar, Medicon Valley Alliance in cooperation with DNB invites you to participate in a second network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present your technology / business plan to any of the…

Medicon Valley Alliance in collaboration with ICON plc invites you to join leading industry experts on biomarker research for a unique, dynamic and interactive evening. Science after Hours is a “moving round table” networking event where you can learn and engage with leading biomarker experts and industry colleagues about compelling scientific insights on the use […]

The Nordic arena for early clinical trials attracts pharmaceutical companies from all over the world. What they seek is high quality trials performed by high performing sites. What can the Nordic countries provide and how can companies within the Medicon Valley make best use of the expertise available right on our doorstep? This seminar aims […]

17 April 2012 / Ørestad / Denmark Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the […]

This seminar will address several of today’s key challenges in drug development leading up to clinical proof of concept. The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning. The final session w ill discuss how […]

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry. […]